• Abdool-Karim SS, Abdool-Karim Q, Friedland G, Lalloo U & El-Sadr WM (2004) Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS 18, 975979.
  • Allen S, Batungwanayo J, Kerlikowske K et al. (1992) Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. The American Review of Respiratory Disease 146, 14391444.
  • Antonucci G, Girardi E, Raviglione MC & Ippolito G (1995) Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. Journal of the American Medical Association 274, 143148.
  • Braun MM, Badi N, Ryder RW et al. (1991) A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. The American Review of Respiratory Disease 143, 501504.
  • Brettle RP, McNeil AJ, Burns S et al. (1996) Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983–1985. AIDS 10, 419430.
  • Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC et al. (2003) The growing burden of tuberculosis: global trends and interaction with the HIV epidemic. Archives of Internal Medicine 163, 10091021.
  • Dybul M, Bolan R, Condoluci D, Cox-Iyamu R, Redfield R, Hallahan CW et al. (2002) Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. Journal of Infectious Diseases 185, 18181821.
  • Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter L & Kim JY (2001) Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bulletin of the World Health Organization 79, 11451151.
  • Glynn JR, Warndorff DK, Fine PEM, Msiska GK, Munthali MM & Ponnighaus JM (1997) The impact of HIV on morbidity and mortality from tuberculosis in sub-Sahara Africa: a study in rural Malawi and review of the literature. Health Transition Review 7 (Suppl. 2), 7587.
  • Gupta SB, Gilbert RL, Brady AR, Livingstone SJ & Evans BG (2000) CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990–1998. CD4 Surveillance Scheme Advisory Group. AIDS 14, 853861.
  • Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O & Salaniponi FML (2001) Preventing antiretroviral anarchy in sub-Sahara Africa. Lancet 358, 410414.
  • Harries AD, Hargreaves NJ, Chimzizi R & Salaniponi FM (2002) Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential. Bulletin of the World Health Organization 80, 464469.
  • Harries A, Maher D & Graham S (2004) TB/HIV: a clinical manual. 2nd Edn. WHO, Geneva.
  • Markowitz N, Hansen NI, Hopewell PC et al. (1997) Incidence of tuberculosis in the United States among HIV-infected persons. Annals of Internal Medicine 126, 123132.
  • Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R & Whitworth JA (2002) HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 16, 597603.
  • Raviglione MC, Harries AD, Msiska R, Wilkinson D & Nunn P (1997) Tuberculosis and HIV: current status in Africa. AIDS 11 (Suppl. B), S115S123.
  • The President's Emergency Plan for AIDS Relief (2004) U.S. Five-year global HIV/AIDS strategy. Available at: (accessed on 2 July 2004).
  • UNAIDS (2004) 2004 report on the global HIV/AIDS epidemic: 4th global report. June 2004. UNAIDS, Geneva.
  • Vella V (2003) Epidemiological estimates of infectious diseases in KwaZulu–Natal. KwaZulu-Natal Epidemiology Bulletin 2, 233.
  • Williams BG & Dye C (2003) Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. Science 301, 15351537.
  • World Health Organization (2004) UNAIDS/WHO Global HIV/AIDS Online database. Available at:
  • World Health Organization (2003a) The WHO and UNAIDS Global Initiative to Provide Antiretroviral Therapy to 3 Million People with HIV/AIDS in Developing Countries by the End of 2005. World Health Organization, Geneva.
  • World Health Organization (2003b) Scaling Up Antiretroviral Therapy in Resource-limited Settings: Treatment Guidelines for a Public Health Approach, 2003 Revision. World Health Organization, Geneva, Switzerland.
  • World Health Organization (2003c) Treatment of Tuberculosis: Guidelines for National Programmes, 3rd edn. WHO, Geneva, WHO/CDS/TB/2003.313.
  • World Health Organization (2005a) Progress on Global Access to HIV Antiretroviral Therapy: An Update on ‘3 by 5’. WHO, Geneva.
  • World Health Organization (2005b) Global tuberculosis control: surveillance, planning, financing. WHO Report 2005. World Health Organization, Geneva, Switzerland (WHO/HTM/TB/2005.349).